JSF Financial LLC Makes New $1.43 Million Investment in Cardinal Health, Inc. $CAH

Key Points

• JSF Financial LLC acquired 6,404 Cardinal Health shares worth approximately $1.43 million in the third quarter. Institutional investors collectively own 87.17% of the company.
• Cardinal Health reported quarterly EPS of $2.91, beating analyst expectations of $2.42, while revenue rose 5.8% year over year to $63.67 billion. The company guided to fiscal 2027 EPS of $12.40–$12.60.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $269.38 versus the stock’s reported $255.86 price; Cardinal Health also pays an annualized $2.06 dividend, yielding 0.8%.

JSF Financial LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,404 shares of the company's stock, valued at approximately $1,425,000.

Several other institutional investors have also recently made changes to their positions in the company. Downshift Financial LLC grew its holdings in Cardinal Health by 3,666.7% during the 3rd quarter. Downshift Financial LLC now owns 113 shares of the company's stock worth $25,000 after acquiring an additional 110 shares in the last quarter. Investors Research Corp purchased a new position in Cardinal Health during the 2nd quarter valued at about $29,000. Maryland Capital Advisors Inc. increased its position in Cardinal Health by 12,600.0% during the 3rd quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company's stock valued at $28,000 after purchasing an additional 126 shares during the period. Allied Private Wealth LLC purchased a new position in Cardinal Health during the 2nd quarter valued at about $30,000. Finally, NBH Bank bought a new stake in shares of Cardinal Health in the 2nd quarter valued at about $31,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Performance

NYSE:CAH opened at $255.86 on Friday. Cardinal Health, Inc. has a fifty-two week low of $158.70 and a fifty-two week high of $259.21. The stock has a market capitalization of $59.25 billion, a P/E ratio of 35.39, a P/E/G ratio of 1.55 and a beta of 0.50. The company's 50-day simple moving average is $236.17 and its 200-day simple moving average is $223.55.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. During the same quarter in the previous year, the firm earned $2.08 EPS. The company's quarterly revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, research analysts forecast that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were given a dividend of $0.5158 per share. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. Cardinal Health's dividend payout ratio is presently 28.49%.

Analyst Ratings Changes

CAH has been the subject of several research reports. Evercore reaffirmed an "outperform" rating and issued a $270.00 price target on shares of Cardinal Health in a research report on Wednesday, August 12th. Weiss Ratings upgraded shares of Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a research note on Thursday, October 8th. JPMorgan Chase & Co. lifted their price objective on shares of Cardinal Health from $215.00 to $260.00 and gave the company a "neutral" rating in a report on Thursday, August 13th. Wells Fargo & Company boosted their price objective on shares of Cardinal Health from $245.00 to $277.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 12th. Finally, Barclays boosted their price objective on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an "overweight" rating in a research note on Thursday, August 13th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $269.38.

Insider Activity

In related news, insider Michelle D. Greene sold 11,650 shares of the business's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the transaction, the insider directly owned 10,330 shares in the company, valued at $2,434,987.60. The trade was a 53.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Mary C. Scherer sold 2,302 shares of the business's stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total value of $546,471.78. Following the transaction, the chief accounting officer owned 2,811 shares in the company, valued at approximately $667,303.29. This trade represents a 45.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 210,271 shares of company stock worth $49,626,657. Company insiders own 0.12% of the company's stock.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.